ArticleInternational journal of clinical oncology2025

Optimal follow-up duration of cardiac function tests in patients treated with trastuzumab: an analysis using the Japanese Adverse Drug Event Report (JADER) database.

Katsuya Makihara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.